Doctor Dolittle musical collapses two months into year-long tour
The UK tour of Doctor Dolittle has collapsed, and will end its run nine months early.
Producers have cited “lower than anticipated advance ticket sales” as the reason for the cancellation.
The musical began its tour in November and has so far only performed at two venues – the Churchill Theatre in Bromley and the Lowry in Salford – out of the planned 21.
The show, which stars Mark Williams, will play its scheduled dates at the Oxford New Theatre from January 15 to 26, when it will then close.
It was due to run until November 2.
Doctor Dolittle is produced by Music and Lyrics, a consortium of regional theatres including Birmingham Hippodrome, Newcastle Theatre Royal, the Lyceum in Sheffield and the Royal and Derngate in Northampton.
Music and Lyrics’ chair, Robert Sanderson, said: “Music and Lyrics was established to create work of scale and imagination for regional presenting venues and over eight years it has met with a high degree of success. On this occasion, Doctor Dolittle has not secured the same degree of support and, sadly, members of the consortium have had no alternative but to foreshorten the planned tour.
“I would like to thank all those involved in creating this breathtaking production, which has been enjoyed by audiences and critics alike. There is still time to see the production in Oxford between 15 and 26 January.”
Audience members who have purchased tickets for cancelled dates should contact their venue to arrange a refund.
We need your help…
When you subscribe to The Stage, you’re investing in our journalism. And our journalism is invested in supporting theatre and the performing arts.
The Stage is a family business, operated by the same family since we were founded in 1880. We do not receive government funding. We are not owned by a large corporation. Our editorial is not dictated by ticket sales.
We are fully independent, but this means we rely on revenue from readers to survive.
Help us continue to report on great work across the UK, champion new talent and keep up our investigative journalism that holds the powerful to account. Your subscription helps ensure our journalism can continue.